BlackRock’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.9M Buy
17,852,427
+170,226
+1% +$539K ﹤0.01% 2515
2025
Q4
$65.4M Buy
17,682,201
+2,848,410
+19% +$9.2M ﹤0.01% 2358
2025
Q3
$39.3M Buy
14,833,791
+120,726
+0.8% +$233K ﹤0.01% 2655
2025
Q2
$14.5M Buy
14,713,065
+220,045
+2% +$220K ﹤0.01% 3212
2025
Q1
$20.9M Buy
14,493,020
+257,597
+2% +$475K ﹤0.01% 2913
2024
Q4
$31.3M Sell
14,235,423
-29,552
-0.2% -$68.9K ﹤0.01% 2757
2024
Q3
$23.5M Buy
14,264,975
+281,313
+2% +$568K ﹤0.01% 2925
2024
Q2
$31M Buy
13,983,662
+11,144,842
+393% +$26.2M ﹤0.01% 2716
2024
Q1
$7.61M Buy
2,838,820
+725,921
+34% +$1.76M ﹤0.01% 3490
2023
Q4
$6.32M Buy
2,112,899
+145,020
+7% +$188K ﹤0.01% 3596
2023
Q3
$1.93M Buy
1,967,879
+660,427
+51% +$956K ﹤0.01% 4010
2023
Q2
$1.82M Sell
1,307,452
-3,515,736
-73% -$4.91M ﹤0.01% 4089
2023
Q1
$7.67M Sell
4,823,188
-685,999
-12% -$3.54M ﹤0.01% 3457
2022
Q4
$34.3M Buy
5,509,187
+950,543
+21% +$6.8M ﹤0.01% 2713
2022
Q3
$30.5M Buy
4,558,644
+264,412
+6% +$1.82M ﹤0.01% 2784
2022
Q2
$27.3M Buy
4,294,232
+530,492
+14% +$3.01M ﹤0.01% 2909
2022
Q1
$17.5M Buy
3,763,740
+1,522,523
+68% +$6.53M ﹤0.01% 3253
2021
Q4
$11.2M Buy
2,241,217
+235,083
+12% +$1.88M ﹤0.01% 3604
2021
Q3
$24.2M Sell
2,006,134
-79,213
-4% -$1.15M ﹤0.01% 3159
2021
Q2
$44.1M Sell
2,085,347
-61,049
-3% -$1.47M ﹤0.01% 2785
2021
Q1
$60.2M Buy
2,146,396
+82,191
+4% +$2.42M ﹤0.01% 2505
2020
Q4
$53.7M Buy
2,064,205
+38,501
+2% +$1.15M ﹤0.01% 2423
2020
Q3
$75.3M Sell
2,025,704
-63,192
-3% -$2.5M ﹤0.01% 2062
2020
Q2
$107M Buy
2,088,896
+134,909
+7% +$5.64M ﹤0.01% 1799
2020
Q1
$61.6M Sell
1,953,987
-114,245
-6% -$6.03M ﹤0.01% 1936
2019
Q4
$123M Sell
2,068,232
-46,931
-2% -$2.11M ﹤0.01% 1838
2019
Q3
$77.5M Buy
2,115,163
+131,743
+7% +$5.22M ﹤0.01% 2034
2019
Q2
$92.3M Buy
1,983,420
+125,747
+7% +$5.91M ﹤0.01% 1964
2019
Q1
$74.6M Sell
1,857,673
-21,226
-1% -$952K ﹤0.01% 2057
2018
Q4
$86.4M Sell
1,878,899
-6
-0% -$289 ﹤0.01% 1904
2018
Q3
$83.4M Buy
1,878,905
+73,673
+4% +$3.38M ﹤0.01% 2082
2018
Q2
$70.7M Buy
1,805,232
+316,635
+21% +$16M ﹤0.01% 2157
2018
Q1
$108M Sell
1,488,597
-16,798
-1% -$1.23M 0.01% 1795
2017
Q4
$99.1M Sell
1,505,395
-16,279
-1% -$876K ﹤0.01% 1887
2017
Q3
$76.3M Buy
1,521,674
+243,468
+19% +$11.7M ﹤0.01% 2017
2017
Q2
$59.2M Sell
1,278,206
-3,738
-0.3% -$137K ﹤0.01% 2137
2017
Q1
$45.3M Buy
1,281,944
+1,278,683
+39,211% +$29.3M ﹤0.01% 2285
2016
Q4
$41K Sell
3,261
-140
-4% -$1.67K ﹤0.01% 3023
2016
Q3
$47K Hold
3,401
﹤0.01% 2984
2016
Q2
$34K Buy
3,401
+2,518
+285% +$41.7K ﹤0.01% 3095
2016
Q1
$15K Buy
883
+506
+134% +$8.14K ﹤0.01% 2982
2015
Q4
$8K Hold
377
﹤0.01% 2976
2015
Q3
$9K Hold
377
﹤0.01% 2769
2015
Q2
$31K Sell
377
-4,399
-92% -$431K ﹤0.01% 2185
2015
Q1
$443K Buy
+4,776
New +$308K ﹤0.01% 1559

Other funds holding ESPR